BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 20427285)

  • 1. Basis for the specificity and activation of the serpin protein Z-dependent proteinase inhibitor (ZPI) as an inhibitor of membrane-associated factor Xa.
    Huang X; Dementiev A; Olson ST; Gettins PG
    J Biol Chem; 2010 Jun; 285(26):20399-409. PubMed ID: 20427285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the protein Z-dependent protease inhibitor interactive-sites of protein Z.
    Qureshi SH; Lu Q; Manithody C; Yang L; Rezaie AR
    Biochim Biophys Acta; 2014 Sep; 1844(9):1631-7. PubMed ID: 24960590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thermodynamic and kinetic characterization of the protein Z-dependent protease inhibitor (ZPI)-protein Z interaction reveals an unexpected role for ZPI Lys-239.
    Huang X; Zhou J; Zhou A; Olson ST
    J Biol Chem; 2015 Apr; 290(15):9906-18. PubMed ID: 25713144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic characterization of the protein Z-dependent protease inhibitor reaction with blood coagulation factor Xa.
    Huang X; Swanson R; Broze GJ; Olson ST
    J Biol Chem; 2008 Oct; 283(44):29770-83. PubMed ID: 18768472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein Z-dependent protease inhibitor (ZPI) is a physiologically significant inhibitor of prothrombinase function.
    Huang X; Swanson R; Kroh HK; Bock PE
    J Biol Chem; 2019 May; 294(19):7644-7657. PubMed ID: 30918026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of factor Xa residues critical for interaction with protein Z-dependent protease inhibitor: both active site and exosite interactions are required for inhibition.
    Rezaie AR; Manithody C; Yang L
    J Biol Chem; 2005 Sep; 280(38):32722-8. PubMed ID: 16079143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of protein Z-dependent inhibitor complex shows how protein Z functions as a cofactor in the membrane inhibition of factor X.
    Wei Z; Yan Y; Carrell RW; Zhou A
    Blood; 2009 Oct; 114(17):3662-7. PubMed ID: 19528533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid oxidation inactivates the anticoagulant function of protein Z-dependent protease inhibitor (ZPI).
    Huang X; Liu B; Wei Y; Beyea R; Yan H; Olson ST
    J Biol Chem; 2017 Sep; 292(35):14625-14635. PubMed ID: 28717005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A computational modeling and molecular dynamics study of the Michaelis complex of human protein Z-dependent protease inhibitor (ZPI) and factor Xa (FXa).
    Chandrasekaran V; Lee CJ; Lin P; Duke RE; Pedersen LG
    J Mol Model; 2009 Aug; 15(8):897-911. PubMed ID: 19172319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin is a major activator of the anticoagulant serpin, protein Z-dependent protease inhibitor.
    Huang X; Rezaie AR; Broze GJ; Olson ST
    J Biol Chem; 2011 Mar; 286(11):8740-51. PubMed ID: 21220417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein Z-dependent protease inhibitor binds to the C-terminal domain of protein Z.
    Rezaie AR; Bae JS; Manithody C; Qureshi SH; Yang L
    J Biol Chem; 2008 Jul; 283(29):19922-6. PubMed ID: 18502758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for catalytic activation of protein Z-dependent protease inhibitor (ZPI) by protein Z.
    Huang X; Yan Y; Tu Y; Gatti J; Broze GJ; Zhou A; Olson ST
    Blood; 2012 Aug; 120(8):1726-33. PubMed ID: 22786881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the heparin-binding site of the protein z-dependent protease inhibitor.
    Yang L; Ding Q; Huang X; Olson ST; Rezaie AR
    Biochemistry; 2012 May; 51(19):4078-85. PubMed ID: 22540147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin activation of protein Z-dependent protease inhibitor (ZPI) allosterically blocks protein Z activation through an extended heparin-binding site.
    Huang X; Swanson R; Olson ST
    J Biol Chem; 2022 Jun; 298(6):102022. PubMed ID: 35551912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering a protein Z-dependent protease inhibitor (ZPI) mutant as a novel antagonist of ZPI anticoagulant function for hemophilia treatment.
    Huang X
    J Thromb Haemost; 2019 Oct; 17(10):1655-1660. PubMed ID: 31423718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of protein-z-mediated inhibition of coagulation factor xa by z-protein-dependent inhibitor: a molecular dynamic approach.
    Dayer MR; Ghayour O; Dayer MS
    ISRN Hematol; 2012; 2012():762728. PubMed ID: 22536522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory properties of the P1 Tyr variant of antithrombin.
    Yang L; Manithody C; Qureshi SH; Rezaie AR
    Biochemistry; 2010 Mar; 49(12):2680-6. PubMed ID: 20184328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Residues of the 39-loop restrict the plasma inhibitor specificity of factor IXa.
    Yang L; Rezaie AR
    J Biol Chem; 2013 May; 288(18):12692-8. PubMed ID: 23530052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the protein Z-dependent protease inhibitor.
    Han X; Fiehler R; Broze GJ
    Blood; 2000 Nov; 96(9):3049-55. PubMed ID: 11049983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein Z circulates in plasma in a complex with protein Z-dependent protease inhibitor.
    Tabatabai A; Fiehler R; Broze GJ
    Thromb Haemost; 2001 Apr; 85(4):655-60. PubMed ID: 11341501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.